Reinhold Öhrlein

Title: Reinhold Öhrlein: Innovator in Neoglycoproteins

Introduction

Reinhold Öhrlein, based in Rheinfelden, Germany, is an accomplished inventor recognized for his significant contributions in the field of biochemistry. With two patents to his name, he has demonstrated a strong commitment to advancing therapeutic compositions through innovative research and development.

Latest Patents

Öhrlein's latest patents focus on neoglycoproteins and polyamide conjugates. These patents describe compositions comprising either a xenoantigenic group or a biologically active group, along with a macromolecular, macro- or microscopic entity, all bound to a polyamide backbone. The processes for their preparation and their subsequent use in therapeutic compositions highlight Öhrlein's expertise in creating complex bioconjugates aimed at enhancing therapeutic efficacy.

Career Highlights

He is currently associated with Novartis AG, a leading global healthcare company that focuses on the research and development of innovative pharmaceuticals. His work within this esteemed company aligns with his passion for pioneering scientific advancements in healthcare solutions.

Collaborations

Throughout his career, Öhrlein has had the opportunity to collaborate with notable colleagues, including Rudolf Duthaler and Andreas Katopodis. These partnerships have enabled a rich exchange of ideas and innovation, contributing to the successful development of groundbreaking therapeutic applications.

Conclusion

Reinhold Öhrlein's dedication to innovation in the field of neoglycoproteins and therapeutic conjugates stands as a testament to the impact of his work. His patents not only reflect his ingenuity but also promise advancements in therapeutic methods for patients around the world. As he continues his journey within Novartis AG, his contributions are sure to shape the future of biotechnology.